Caris Life Sciences Q3 Earnings Fall, Revenue Rises; Shares Drop After Hours

05:10 PM EST, 11/04/2026 (MT Newswires) -- Caris Life Sciences (CAI) reported Q3 earnings late Wednesday of $0.05, down from $0.08 a year earlier. Analysts polled by FactSet expected $0.03. Revenue for the quarter ended Sept. 30 was $275.4 million, up from $216.8 million a year earlier. Analysts expected $255.4 million. For 2026, the company raised its revenue guidance to $1.04 billion to $1.05 billion from $1.03 billion to $1.04 billion previously. Analysts expect $1.03 billion. Shares of Caris Life Sciences were down more than 14% in after-hours trading.